Semmo M - Search Results

1

Elevated levels of endocannabinoids in chronic hepatitis C may modulate cellular immune response and hepatic stellate cell activation.

Patsenker E, Sachse P, Chicca A, Gachet MS, Schneider V, Mattsson J, Lanz C, Worni M, de Gottardi A, Semmo M, Hampe J, Schafmayer C, Brenneisen R, Gertsch J, Stickel F, Semmo N. Patsenker E, et al. Among authors: semmo m. Int J Mol Sci. 2015 Mar 27;16(4):7057-76. doi: 10.3390/ijms16047057. Int J Mol Sci. 2015. PMID: 25826533 Free PMC article.

2

T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.

Wang Q, Sachse P, Semmo M, Lokhande M, Montani M, Dufour JF, Zoulim F, Klenerman P, Semmo N. Wang Q, et al. Among authors: semmo m. J Viral Hepat. 2015 Dec;22(12):1068-78. doi: 10.1111/jvh.12428. Epub 2015 Jun 15. J Viral Hepat. 2015. PMID: 26075501

3

Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment.

Weiss L, Wustmann K, Semmo M, Schwerzmann M, Semmo N. Weiss L, et al. Among authors: semmo m. Case Rep Gastroenterol. 2018 Feb 21;12(1):92-98. doi: 10.1159/000486951. eCollection 2018 Jan-Apr. Case Rep Gastroenterol. 2018. PMID: 29606942 Free PMC article.

4

Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Gassanov N, Semmo N, Semmo M, Nia AM, Fuhr U, Er F. Gassanov N, et al. Among authors: semmo n, semmo m. Eur J Clin Pharmacol. 2011 Apr;67(4):333-346. doi: 10.1007/s00228-011-1006-7. Epub 2011 Feb 17. Eur J Clin Pharmacol. 2011. PMID: 21327910 Review.

5

Gluteal rhabdomyolysis and renal failure due to simvastatin and amiodarone.

Semmo M, Dhayat NA. Semmo M, et al. Kidney Int. 2016 Oct;90(4):909. doi: 10.1016/j.kint.2016.06.025. Kidney Int. 2016. PMID: 27633874 Free article. No abstract available.

6

Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients Treated With Tolvaptan.

Anderegg MA, Dhayat NA, Sommer G, Semmo M, Huynh-Do U, Vogt B, Fuster DG. Anderegg MA, et al. Among authors: semmo m. Kidney Med. 2020 Feb 26;2(2):162-171. doi: 10.1016/j.xkme.2019.11.008. eCollection 2020 Mar-Apr. Kidney Med. 2020. PMID: 32964204 Free PMC article.

7

Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.

Bargagli M, Dhayat NA, Anderegg M, Semmo M, Huynh-Do U, Vogt B, Ferraro PM, Fuster DG. Bargagli M, et al. Among authors: semmo m. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1007-1014. doi: 10.2215/CJN.13861119. Epub 2020 Jun 11. Clin J Am Soc Nephrol. 2020. PMID: 32527945 Free PMC article.

8

Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.

Bally L, Gubler P, Thabit H, Hartnell S, Ruan Y, Wilinska ME, Evans ML, Semmo M, Vogt B, Coll AP, Stettler C, Hovorka R. Bally L, et al. Among authors: semmo m. Kidney Int. 2019 Sep;96(3):593-596. doi: 10.1016/j.kint.2019.03.006. Epub 2019 Mar 20. Kidney Int. 2019. PMID: 31133457 Free article. Clinical Trial.

9

Short-term fully closed-loop insulin delivery using faster insulin aspart compared with standard insulin aspart in type 2 diabetes.

Bally L, Herzig D, Ruan Y, Wilinska ME, Semmo M, Vogt A, Wertli MM, Vogt B, Stettler C, Hovorka R. Bally L, et al. Among authors: semmo m. Diabetes Obes Metab. 2019 Dec;21(12):2718-2722. doi: 10.1111/dom.13861. Epub 2019 Oct 8. Diabetes Obes Metab. 2019. PMID: 31464063 Free article. Clinical Trial.

10

The TRPP subfamily and polycystin-1 proteins.

Semmo M, Köttgen M, Hofherr A. Semmo M, et al. Handb Exp Pharmacol. 2014;222:675-711. doi: 10.1007/978-3-642-54215-2_27. Handb Exp Pharmacol. 2014. PMID: 24756726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page